(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)

NCT05923502 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Follicular Lymphoma
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Richter Syndrome
Marginal Zone Lymphoma
Peripheral T Cell Lymphoma
Diffuse Large B Cell Lymphoma

Interventions

DRUG: Duvelisib

Sponsor

Ruijin Hospital